Viemed Healthcare
Provides home ventilation, sleep therapy, and HME support for U.S. patients.
Something off on this page? Send us feedback.
Profile
Provides home respiratory care, sleep therapy, HME rentals and supplies, connected health, and partner programs for U.S. patients. Ventilator rentals remain the core revenue line, while Medicare and CMS fee-for-service pricing shape reimbursement.
Built from 2006 operating roots in Sleep Management and Home Sleep Delivered, the platform centers on home respiratory care and HME. Service lines include non-invasive ventilation, sleep testing and PAP therapy, CPAP resupply, connected-health monitoring, behavioral coaching, hospital partner programs, and healthcare staffing.
Most activity is concentrated in the United States, with Lafayette, Louisiana as the operating base. HMP, East Alabama HomeMed, and Lehan added regional HME scale, sleep resupply, hospital-network ties, and maternal-health products.
Execution depends on clinical setup, patient education, equipment compliance, resupply workflows, and integration of acquired branches. Medicare is the primary payer, and a majority of revenue follows CMS fee-for-service pricing guidelines.
Company facts
Categories
Key statistics
Year to date +22.3% · Average volume (30d) 433.4K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Target |
|---|---|---|---|---|---|
| Aug 24, 2026 | Barrington | Target | $14 | ||
| Aug 6, 2026 | Freedom Broker | Downgrade | Buy | Hold |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026Q2 FY26 | $0.12 | $0.07 | −41.7% | $78.0M | $78.1M | +0.1% | −15.83% |
| May 5, 2026Q1 FY26 | $0.09 | $0.06 | −33.3% | $74.4M | $75.4M | +1.4% | −12.16% |
| Mar 4, 2026Q4 FY25 | $0.12 | $0.14 | +16.7% | $77.7M | $76.2M | −2.0% | −7.49% |
| Nov 5, 2025Q3 FY25 | $0.09 | $0.09 | 0.0% | $77.7M | $71.9M | −7.4% | −2.64% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $59.1M | $63.1M | $71.9M | $76.2M | $75.4M | $78.1M | |
| Gross profit | $33.3M | $36.4M | $41.3M | $44.1M | $42.4M | $44.7M | |
| Operating income | $3.8M | $4.5M | $6.1M | $8.7M | $4.7M | $5.1M | |
| Net income | $2.6M | $3.2M | $3.5M | $5.6M | $2.6M | $2.8M | |
| Diluted EPS | $0.06 | $0.08 | $0.09 | $0.14 | $0.06 | $0.07 | |
| Gross margin | 56.3% | 57.7% | 57.5% | 57.9% | 56.3% | 57.2% | |
| Operating margin | 6.5% | 7.2% | 8.5% | 11.4% | 6.3% | 6.5% |
Fiscal years (4-quarter sums)FY21 $117.1M · FY22 $138.8M · FY23 $183.0M · FY24 $224.3M · FY25 $270.3M
Revenue by product · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $10.7M · Total debt $11.6M · Total assets $204.2M · Shareholders' equity $144.0M
Dividends
No dividends on record.
Ownership
Shares outstanding 38.09M · Float 32.88M · 86.3% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 4.79M | 12.57% | 13F | Aug 7, 2026 |
| Thrivent Financial for Lutherans | 2.71M | 6.80% | 13G | Apr 29, 2025 |
| Forager Capital Management, LLC | 2.14M | 5.62% | 13F | Aug 14, 2026 |
| Michael Moore · officer: President | 1.77M | 4.66% | Form 4 | Mar 20, 2026 |
| Vanguard Capital Management LLC | 1.32M | 3.47% | 13F | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jun 24, 2026 | Timothy Smokoff | director | −20,000 | $11.50 |
| Jun 25, 2026 | William Frazier | director, officer: Chief Medical Officer | −10,000 | $11.72 |
| Mar 20, 2026 | Michael Moore | officer: President | −65,000 | $8.77 |
| Mar 19, 2026 | Michael Moore | officer: President | −40,232 | $9.21 |
| Mar 18, 2026 | Michael Moore | officer: President | −31,570 | $9.42 |
Peers
- AdaptHealth
National HME, sleep, oxygen, and ventilation service peer
- Accendra Health
Apria-backed home respiratory, sleep, and HME platform
- Linde
Lincare home respiratory and oxygen services inside Linde
- ResMed
Sleep and breathing-health device ecosystem competitor
- Inogen
Home oxygen and respiratory-device competitor
- Option Care Health
Adjacent post-acute home and alternate-site care provider
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Viemed Healthcare | $9.00 | +1.93% | $335.9M | 24.2 | 17.9 | 1.1 | +23.9% |
| AdaptHealth | $5.77 | −0.52% | $787.8M | — | — | 0.3 | −7.5% |
| Accendra Health | $1.20 | −1.54% | $92.7M | — | — | 0.0 | −10.1% |
| Linde | $489.36 | −0.03% | $226.45B | 31.6 | 26.2 | 6.4 | +9.4% |
| ResMed | $240.33 | +0.01% | $34.86B | 23.1 | 19.8 | 6.2 | +8.6% |
| Inogen | $5.50 | −0.09% | $148.9M | — | — | 0.4 | +3.0% |
| Option Care Health | $23.90 | 0.00% | $3.58B | 18.0 | 12.2 | 0.6 | +1.9% |
| Median | 23.1 | 19.8 | 0.5 | +2.5% |








